BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 20, 2010
 |  BC Week In Review  |  Company News  |  Deals

EntreMed, Selected Value Therapeutics I LLC deal

EntreMed granted Selected Value Therapeutics I an option to license rights to develop and commercialize ENMD-2076 in China and Taiwan. The inhibitor of aurora kinase...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >